Epidiolex for Europe may come from UK-grown cannabis
3rd December 2018 - News analysis |
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
Celebrating our 10th anniversary – Unlock our special offer today
The CBD-based epilepsy drug Epidiolex could become available in Europe, manufactured from cannabis already growing in eastern England
British detox products supplier Equilibrium Labs is to add CBD to its Sober Up shots next year, in a move that could benefit those with foggy heads thanks to a new CBD beer also hitting shelves.
A CBD-infused version of Sober Up, which is based on a proprietary blend of herbs and extracts, should be available from early 2019.
A Big Tobacco company which invested in a medical cannabis startup will not influence how the smaller firm is run, according to bosses at Oxford Cannabinoid Technologies
Investment in Europe continues as companies in the medical cannabis sector anticipate further loosening of regulations. In the pure-CBD sector, two American firms are eyeing expansion
The number of cannabidiol-based pharmaceutical products in the pipeline continues to grow, with the US Food and Drug Administration (FDA) recently granting yet another orphan drug designation for CBD
American CBD company CV Sciences announces sales of $13.6m in the third quarter of 2018 and $34m over the first nine months of the year while Terra Tech reveals merger
Two North American companies have announced collaborations with established drug delivery firms to produce and expand distribution for oral CBD strips – soluble strips that dissolve in the mouth
Police are clamping down on the new wave of CBD shops in France. Products have been confiscated and some stores have even been closed down.
Canadian company C21 Investments has been issued a licence to import finished CBD products as well as raw extracts and concentrates into Ukraine
CBD could be an ideal product for direct selling due to the large amount of confusion over the compound, according to a US media company
Colorado-based Mile High Labs has announced $35m in Series A funding from institutional and private equity investors to expand its CBD production capacity
Australia may become a big exporter of organic hemp products, especially to Asia, according to the president of the Australian Industrial Hemp Alliance (AIHA)
CBD and other legal cannabis products appear to be dividing the tobacco industry.
Around half of the major Western tobacco companies have publicly announced an interest in the cannabis and cannabis-product spheres with the other half continuing to deny any interest at all in the market.
Many British CBD companies are finding their voice and their own way to make the regulations that ban them from making medical claims work for them and the consumer
A major CBD show is to be held in Las Vegas next month in what is billed as “an epic collaboration of two industries”. The CBD.io event will take place on 9th and 10th November in conjunction with VapExpo
Prospects for CBD in Brazil depend hugely on the outcome of the forthcoming presidential election, in which the far right-wing candidate Jair Bolsonaro has emerged as a very strong favourite
A former supermodel and a vegan food retailer are the latest famous names to team up with CBD producers to create new American brands
Canadian company Emerald Health Therapeutics is set to sign a deal to use an extraction facility capable of processing 1000 tonnes of biomass to produce 600m softgel CBD capsules a year
Canadian CBD company Maricann has continued its European expansion with plans to open a retail location in Zurich, Switzerland
Intrexon, an American biotech company listed on the Nasdaq stock exchange, has announced a development in its microbial platform capable of producing cannabinoids for medical use
Tobacco giant Imperial Brands is looking to new markets such as cannabis and CBD in the near future. “At the moment we are looking to understand this space”, said Alison Cooper, CEO of Imperial Brands, about the cannabis market in a recent interview with business channel Bloomberg TV. The firm is showing increased interest in how the US cannabis and CBD market » Continue Reading.
Namaste Technologies, the company behind Canadian online cannabis sales platform CannMart, is planning an advance into Europe, taking CBD products into the UK market as food supplements
Australian company MGC Pharmaceuticals has signed a deal to distribute cannabis-based pharmaceutical products throughout Europe and to produce and cultivate medical cannabis in Malta
Companies from Canada’s large cannabis sector are continuing to invest in central and eastern Europe
Rare cannabinoids that cannot practically be extracted from hemp will instead be manufactured by specially-created micro-organisms in a partnership between a Canadian and a US company
The town of Nelas in north central Portugal is to be the site of a new CBD oil factory producing medicinal products extracted from cannabis sativa for export to America and within Europe
A Polish CBD company has been acquired by a publicly traded Canadian medicinal cannabis company in a cash-and-shares deal worth more than $15m USD plus future incentives
Vaping businesses in the US are experiencing a shift in consumer preferences for methods of extracting CBD and THC from cannabis, with more manufacturers developing distillers to help meet the growing demand for purer products
Isodiol International, a Canadian-based pharmaceutical producer, is to enter the vaping industry through the acquisition of US e-liquid firm Bradley’s Bioscience
Enovap, an innovative French hardware manufacturer, has announced plans to move into the US market, where it hopes to apply its technology to medicinal cannabis use
E-cigarette firms who already have devices on the market are manoeuvring to see how their products can serve the growing marijuana industry – and they face competition there from some well-financed start-ups.
39 U.S. states and the District of Columbia have laws that legalise and/or decriminalise marijuana use or possession to various extents. E-cig companies are well positioned to enter the emerging marijuana market because of their technical expertise and intimate knowledge of the science behind vaporisers, and several types of cannabis-compatible vaporisers, or “c-cigs”, may succeed in the U.S. market.